Delta 9 Cannabis Inc
TSX:DN
Delta 9 Cannabis Inc
TSX:DN
Price:
0.01
CAD
Market Closed
Market Cap:
CA$3.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Delta 9 Cannabis Inc
TSX:DN
|
CA |
|
G
|
Garg Furnace Ltd
BSE:530615
|
IN |
|
Linedata Services SA
PAR:LIN
|
FR |
|
AV Concept Holdings Ltd
HKEX:595
|
HK |
|
Y
|
Yuilrobotics Co Ltd
KOSDAQ:388720
|
KR |
|
Tifico Fiber Indonesia Tbk PT
IDX:TFCO
|
ID |
|
I
|
IAG Holdings Ltd
HKEX:8513
|
SG |
|
Roolife Group Ltd
ASX:RLG
|
AU |
|
Aleafia Health Inc
TSX:AH
|
CA |
|
N
|
Nippon Coke & Engineering Co Ltd
TSE:3315
|
JP |
|
Southern Province Cement Company SJSC
SAU:3050
|
SA |
|
Seeka Ltd
NZX:SEK
|
NZ |
|
H
|
H-One Co Ltd
TSE:5989
|
JP |
|
TechTarget Inc
NASDAQ:TTGT
|
US |
|
Renova Inc
TSE:9519
|
JP |
|
Hyundai Wia Corp
KRX:011210
|
KR |
|
Astronics Corp
NASDAQ:ATRO
|
US |
|
Kozo Keikaku Engineering Inc
TSE:4748
|
JP |
|
Ultralife Corp
NASDAQ:ULBI
|
US |
|
A
|
Absa Bank Ltd
JSE:ABSP
|
ZA |
|
C
|
Carbonxt Group Ltd
ASX:CG1
|
AU |
|
P
|
Posiflex Technology Inc
TWSE:8114
|
TW |
|
Midland States Bancorp Inc
NASDAQ:MSBI
|
US |
|
S
|
Sherritt International Corp
XMUN:HRT
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of DN.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DN
Multiples-Based Value
Not Available
Multiples Across Competitors
DN Competitors Multiples
Delta 9 Cannabis Inc Competitors
Delta 9 Cannabis Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Delta 9 Cannabis Inc
TSX:DN
|
3.5m CAD | 0 | -0.2 | -36.3 | -2.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.2 | 29.7 | 16.4 | 23.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
